The single-gene GSEA analysis of HERC6 in this study indicates that this gene may participate in the regulation of the disease in DCM patients by inhibiting the activation of myeloid cells and neutrophils involved in immune responses, negatively regulating inflammatory responses, and promoting biological processes such as cardiac contraction and oxidative phosphorylation. This evidence concerns the gene HERC6 and familial dilated cardiomyopathy.